Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

11.94
Delayed Data
As of Feb 05
 +0.25 / +2.14%
Today’s Change
9.16
Today|||52-Week Range
17.55
-29.14%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a +59.13% increase from the last price of 11.94.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.39
Sales
$28.6M
Reporting Date
Feb 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -552.08%
 
 
 
 
 
 
Growthannually -41.53%
 
 
 
 
 
 

Sales

Growthquarterly -52.27%
 
 
 
 
 
 
Growthannually 10.05%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.